Jonathan Collins
Analyst · Morgan Stanley. Please go ahead
Thank you, Jerre. Good morning, everyone. Slide 15 is an overview of our 2021 fourth quarter and full year results compared with the same periods in 2020. Fourth quarter revenue topped $560 million, an increase of more than $100 million compared to the same period in 2020, driven primarily by inorganic growth as the ProQuest acquisition closed on December 1 as well as 4% organic growth which was below expectations caused by the factors Jerre just highlighted on the previous slide. Adjusted EBITDA for the quarter was $257 million for a profit margin that approached 46% and represented a more than 300 basis point increase from the same period in the prior year. Net loss attributable to ordinary shares was $130 million in the quarter and increased as a result of substantially higher mark-to-market expense on the private warrants and higher interest expense. Adjusted diluted EPS for Q4 was $0.23 and represented a $0.01 increase over Q4 of 2020. For the full year, revenues approached $1.180 billion, growth of more than $600 million compared to 2020 on strong inorganic growth and solid organic growth of 4.5%. Adjusted EBITDA for the quarter was $800 million, a more than $300 million increase over the prior year, leading to a margin expansion of 450 basis points as a result of strong conversion on the sales growth and delivery of $70 million of cost synergies, primarily from the CPA acquisition. The full year net loss attributable to ordinary shares was $312 million, an improvement of nearly $40 million compared with 2020 on a dramatically lower mark-to-market expense on the private warrants which was partially offset by higher interest and preferred dividend expenses. Adjusted diluted EPS for the full year was $0.72, an increase of $0.08 compared to 2020. And finally, we generated $459 million of adjusted free cash flow, an increase of $158 million for a growth of more than 50% compared to 2020. Please turn with me now to Page 16 for a closer look at the adjusted revenue and adjusted EBITDA growth for the full year. 2021 top and bottom line growth over 2020 was driven by four key factors. First, organic growth of 4.5% added $57 million to the top line and $30 million to the bottom line for a profit conversion of 52%. This was driven by solid subscription growth of 3.5% and strong reoccurring growth of almost 8.5% but was curtailed by lower-than-expected transactional growth which came in just under 6%. The profit contribution was delivered by maintaining strong cost discipline despite the transactional sales shortfall late in the fourth quarter. Second, inorganic growth contributed $530 million to the top line and $207 million to the bottom line for a profit conversion of 39% on a pre-cost synergy basis. This growth is primarily attributed to having a full year contribution from the CPA and DRG acquisitions as well as the one month contribution for ProQuest, all net of the Techstreet divestiture. Third, cost synergies, net of certain operating expenses required to achieve them, contributed $70 million of incremental profit in 2021 compared to the prior year, the lion's share coming from the CPA acquisition which contributed a total of $100 million on a run rate basis and represents 1/3 more than was originally committed. Finally, the translation impact of subsidiaries denominated in foreign currencies added $17 million of revenue and $7 million of profit. As for most of the year, the dollar weakened compared to a basket of these currencies. Please turn with me now to Page 17 to understand how the $800 million of profit converted to cash flow. Free cash flow topped $200 million in 2021 which represented growth of more than 30% over the prior year. Adjusted free cash flow of $459 million exceeded the prior year by $158 million for a growth of more than 50%. Growth in adjusted EBITDA was partially offset by higher onetime costs which were primarily attributed to acquiring and integrating businesses, higher interest to fund the acquisitions and an increase in working capital requirements compared to the prior year that were primarily associated with the timing of patent renewal payments in the services portion of the CPA business. This episodic working capital swing is the cause of the nearly 500 basis point compression in the adjusted free cash flow conversion. Please move with me now to Slide 18, where we turn the page on 2021 and take a look at our full year guidance for 2020 [ph]. As we look forward to this year, our guidance remains unchanged from what we provided last month. We expect revenue to grow nearly $1 billion to $2.84 billion at the midpoint of the range, fueled by the ProQuest acquisition and accelerating organic growth of 6.5%. We anticipate adjusted EBITDA will approach $1.2 billion towards the midpoint of the range for a profit margin of approximately 42% which represents a slight compression compared to last year as the cost synergies of the ProQuest acquisition will not be fully recognized until next year. Adjusted free cash flow is expected to reach $700 million at the midpoint of the range for a conversion approaching 60%. Adjusted diluted earnings are expected at $0.90 per share at the midpoint of the range as a result of higher earnings and will likely be augmented by buybacks under our $1 billion share repurchase authorization. Please turn me now to Page 19 for the major drivers of the expected revenue and profit growth for this year compared to last. As with the comparisons we provided for last year's top and bottom line growth, this year's results will be driven by the same four factors. First, organic growth is expected to accelerate by 200 basis points to 6.5% and deliver approximately $120 million of revenue growth at about $70 million of profit growth for a profit conversion of more than 55%. As you can see in the table on the lower left of the page, this growth rate expansion is attributable in equal parts to four items: one, improved pricing; two, higher renewal rates; three, significant cross-selling of all our products across the four customer verticals; and four, improved transactional sales. The One Clarivate go-to-market strategy will deliver these improvements as we move through the year. Second, inorganic growth is expected to contribute an additional $865 million of sales, $285 million of profit growth for a profit conversion of just over 30% as a result of the ProQuest acquisition but on a pre-cost synergy basis. Third, cost synergies associated with the transaction are expected to add $50 million to profit as we recognize about half of the total amount this year with the remaining half to be achieved next year. Finally, we expect a strong dollar trend we saw late last year could continue into this year, resulting in about a $30 million headwind to revenue and a $15 million flow-through to profit. Slide 20 illustrates the expected seasonality of our revenues for this year which remains relatively consistent with last year's pro forma results. The stacked bars on the chart represent our actual reported and pro forma revenues for last year. As you can see, they improved sequentially from Q1 to Q2 then modestly abated in Q3 before improving again sequentially in Q4. We believe this represents the normal seasonality of our business after the full effect of the acquisitions. The solid line on the top represents our expectation for this year's revenue phasing which is generally in line with what we experienced last year on a pro forma basis and we expect our growth to accelerate as we move through the year. Please turn with me now to Page 21 for more detail on how we expect the full year adjusted EBITDA will convert to adjusted free cash flow. Our full year outlook for adjusted free cash flow is $700 million at the midpoint of the range and represents an increase of nearly $0.25 billion compared to last year. We anticipate the profit growth of nearly $400 million will be partially offset by slightly higher interest associated with that used to fund the acquisitions, higher cash taxes on the profit growth and modestly higher capital requirements as increased capital spending will be ameliorated by lower working capital needs. This outlook anticipates a nearly 200 basis point expansion of the cash flow conversion and we expect $0.60 of every dollar of incremental profit will convert to cash. Please turn with me now to Page 22, where I will outline how the expectations for this year position us to maintain our trajectory towards the midterm financial targets we outlined in November of last year. In the upper left of the page, you will see that with an organic growth rate next year comparable to this year's expectation, we will reach $3 billion of revenue. At that level, you can see in the upper right, we expect profit margins to expand meaningfully on the profit conversion from the organic growth and the realization of the cost synergies from ProQuest. The profit growth and the anticipated impact of the share repurchase program will lead to continued growth in adjusted diluted earnings per share, as outlined in the lower left. And finally, in the lower right, we expect adjusted free cash flow to grow by more than $100 million next year, leading to a cumulative generation of more than $1.5 billion between this year and next. Please turn with me now to Page 23, where I will outline how we plan to utilize this cash. The pie chart on the left of the page illustrates our capital allocation priorities. Working clockwise from the top, you will note we plan to service the dividends on the mandatory convertible preferred shares with cash as we did in Q4 of last year and have already in Q1 of this year. Next, we plan to pay down our cash flow revolver balance to zero over this period and, combined with the required amortization on the term loans, will contribute to our deleveraging which I'll touch on in a moment. Third, we plan to utilize a portion of the cash flow to complete the integration of the ProQuest acquisition. However, we do not expect any substantive M&A transactions until our stock price improves meaningfully from current levels. And finally, on the left of the pie, you will see we plan to set aside approximately 2/3 of our cash flow to repurchase stock as we simply see no greater investment than to buy back more than 10% of the company at the current price level. Moving to the right of the page, you'll notice on the top, we plan to migrate our net leverage to between three and four turns by the end of next year and this will largely be accomplished through the adjusted EBITDA growth I've outlined on the prior pages and the modest debt paydown we set aside in the capital allocation I just outlined. And finally, on the bottom, we expect our average share count to decline next year as a result of the buyback program which will further accelerate our earnings per share growth. Slide 24 highlights the compelling investment opportunity that Clarivate represents. And here, I'll work clockwise from the top. Our leading brands serve an atomized and global customer base across the broader information and software services landscape which represents a massive TAM estimated at over $100 billion. And the resiliency of this business is remarkable with approximately 80% of our revenue coming from subscription and reoccurring sales. What's more, our subscribers renew at greater than 90% each year, providing a spectacular base for organic growth. All of the products and services we provide deliver significant operating leverage as manifested in our high profit margins as we utilize the "build it once, sell it many times" approach in our product development. Not only does this deliver excellent margins but our free cash flow generation is poised to lead our category as we integrate the last few major acquisitions and execute our plan to deliver more than $1.5 billion between this year and next. Finally, as Jerre highlighted earlier, we now have the accomplished leadership team in place to position Clarivate to scale by achieving a substantial position in the four customer verticals we serve: academic and government, life sciences and health care, professional services and consumer products, manufacturing and technology. I'd like to conclude by thanking all of the more than 11,400 Clarivate teammates around the world for their tireless work to delight our customers and in doing so, positioning us to deliver exceptional results for our shareholders in the months, quarters and years ahead. Thank you all for listening in this morning. I'm now going to turn the call back over to Tom to take your questions. And as a reminder, please limit yourself to one question and return to the queue. Tom, please go ahead.